Boston Therapeutics Short Interest Ratio and Short Volume

Short interest is the volume of Boston Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 1,800 shares of BTHE short.

Boston Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,800 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Boston Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Boston Therapeutics: Kaya Holdings, Inc. (0.00%), Wellness Center USA, Inc. (0.00%), Intellipharmaceutics International Inc. (0.00%), American Bio Medica Co. (0.00%), Amarantus BioScience Holdings, Inc. (0.00%), VG Life Sciences Inc. (0.00%), Immune Pharmaceuticals, Inc. (0.00%), ImmunoCellular Therapeutics, Ltd. (0.00%), W World Corp. (0.00%), and Achaogen, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling BTHE is an investing strategy that aims to generate trading profit from Boston Therapeutics as its price is falling. To short Boston Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Boston Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Boston Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTHE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTHE, twice per month. The most recent reporting period available is March, 31 2021.